1 to 9 of 18 results

US FTC puts divestment conditions on Watson's acquisition of Actavis


The USA's Federal Trade Commission will require Watson Pharmaceuticals (NYSE: WPI) and fellow generic…

ActavisGenericsLegalMergers & AcquisitionsNorth AmericaNovartisPar PharmaceuticalsSandozWatson Pharmaceuticals

Ring in generics in 2012 and beyond, says Zacks Equity Research


The New Year is expected to be a happy beginning for generic companies like Teva Pharmaceuticals (Nasdaq:…

Dr Reddy's LaboratoriesGenericsMarkets & MarketingNorth AmericaPatentsRanbaxy LaboratoriesSandozTeva Pharmaceutical IndustriesWatson Pharmaceuticals

US FDA warns that zonisamide increases risk of metabolic acidosis


US regulators have issued a warning on Japanese drugmaker Eisai's off-patent anti-epileptic Zonegran…

EisaiNovartisSandozWatson PharmaceuticalsZonegranZonisamide

Watson's 2nd-qtr 2008 profit jumps 66%


US generic and branded drugmaker Watson Pharmaceuticals' second-quarter 2008 profit jumped 66% year-on-year…

Metoprolol SuccinateSandozToprol XLWatson Pharmaceuticals

Watson's 1st-qtr 2008 net income jumps 60%


US generic and branded drugmaker Watson Pharmaceuticals' first-quarter 2008 net income totaled $51.0…

Alendronate SodiumFerrlecitFosamaxMetoprolol SuccinateOxycodone HClOxyContinSandozSodium ferric gluconateStriantTestodermTestosteroneToprol XLWatson Pharmaceuticals

1 to 9 of 18 results

Back to top